People in disadvantaged communities are less likely to access COVID antivirals. That needs to change.
- Post doctoral researcher and medical epidemiologist, The Peter Doherty Institute for Infection and Immunity
Here’s who is eligible, the benefits and side effects to consider.
Contact Nicole for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- Joined
